000 01556 a2200469 4500
005 20250517071111.0
264 0 _c20161020
008 201610s 0 0 eng d
022 _a2045-7634
024 7 _a10.1002/cam4.580
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Peggy L
245 0 0 _aPhysician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey.
_h[electronic resource]
260 _bCancer medicine
_cFeb 2016
300 _a209-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBreast Neoplasms
_xepidemiology
650 0 4 _aDrug Prescriptions
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasm Staging
650 0 4 _aPhysicians
650 0 4 _aPostmenopause
650 0 4 _aPractice Patterns, Physicians'
650 0 4 _aReceptor, ErbB-2
_xmetabolism
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aReceptors, Progesterone
_xmetabolism
650 0 4 _aRisk Factors
650 0 4 _aSurveys and Questionnaires
650 0 4 _aUnited States
_xepidemiology
700 1 _aHao, Yanni
700 1 _aXie, Jipan
700 1 _aLi, Nanxin
700 1 _aZhong, Yichen
700 1 _aZhou, Zhou
700 1 _aSignorovitch, James E
700 1 _aWu, Eric Q
773 0 _tCancer medicine
_gvol. 5
_gno. 2
_gp. 209-20
856 4 0 _uhttps://doi.org/10.1002/cam4.580
_zAvailable from publisher's website
999 _c25559246
_d25559246